Back to Ophthalmology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Diabetic Macular Edema

Overview

Spherix’s coverage of diabetic eye disease focuses on diabetic macular edema and diabetic retinopathy –  providing the big-picture analysis of the current market landscape, including ophthalmologists’ understanding, diagnosis, and treatment of the disease while monitoring perceptions and uptake of new entrants.

Services Available

Prepping for the pipeline

  • Diabetic Macular Edema (US)

Exploring the patient journey

  • Treatment Switching in Diabetic Macular Edema (US)

Benchmarking new brand performance

  • Beovu (Novartis) in Diabetic Macular Edema (US)*

  • Faricimab (Genentech) in Diabetic Macular Edema (US)*

  • Byooviz (Samsung Bioepis and Biogen) Ranibizumab Biosimilar (US)

  • FYB201 (Coherus BioSciences) Ranibizumab Biosimilar (US)*

*Pending approvals and launch

Gauging impact of disruptive events

  • Ophthalmology Biosimilars Today and Tomorrow (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Diabetic Macular Edema Coverage